An inexpensive distance learning solution for delivering high-quality live broadcasts.

Providing an adequate method of distance learning is a challenge faced by many multicenter residency programs. The delivery of live didactics over the Internet is a convenient means of providing a uniform and equivalent educational experience to residents at distant sites. An application called MedCast has been developed with use of existing technologies, without the need for costly commercial products or equipment. MedCast captures the presenter's computer screen and audio from a microphone source to produce a streaming video that is transmitted online and archived on a local server. Offsite residents can view broadcasts in real time or access archived conference sessions for later viewing. MedCast is available for download at no cost and offers several advantages, including a user-friendly graphical display interface, near-perfect preservation of image quality, and cost efficiency. Future plans include objective assessment of the efficacy of MedCast by comparing postlecture examinations to help evaluate for any differences between on- and offsite residents in terms of knowledge gained. A movie clip to supplement this article is available online at http://radiographics.rsnajnls.org/cgi/content/full/285085701/DC1.

CT volumetric analysis of pleural effusions: a comparison with thoracentesis volumes.

RATIONALE AND OBJECTIVES: The primary objective of this study was to compare computed tomography (CT) volumetric analysis of pleural effusions with thoracentesis volumes. The secondary objective of this study was to compare subjective grading of pleural effusion size with thoracentesis volumes. MATERIALS AND METHODS: This was a retrospective study of 67 patients with free-flowing pleural effusions who underwent therapeutic thoracentesis. CT volumetric analysis was performed on all patients; the CT volumes were compared with the thoracentesis volumes. In addition, the subjective grading of pleural effusion size was compared with the thoracentesis volumes. RESULTS: The average difference between CT volume and thoracentesis volume was 9.4 mL (1.3%) ± 290 mL (30%); these volumes were not statistically different (P = .79, paired two-tailed Student's t-test). The thoracentesis volume of a "small," "moderate," and "large" pleural effusion, as graded on chest CT, was found to be approximately 410 ± 260 cc, 770 ± 270 mL and 1370 ± 650 mL, respectively; the thoracentesis volume of a "small," "moderate," and "large" pleural effusion, as graded on chest radiograph, was found to be approximately 610 ± 320 mL, 1040 ± 460 mL, and 1530 ± 830 mL, respectively. CONCLUSIONS: CT volumetric analysis is an accessible tool that can be used to accurately quantify the size of pleural effusions.

Phase I trial of induction histone deacetylase and proteasome inhibition followed by surgery in non-small-cell lung cancer.

INTRODUCTION: Despite complete surgical resection survival in early-stage non-small-cell lung cancer (NSCLC) remains poor. On the basis of prior preclinical evaluations, we hypothesized that combined induction proteasome and histone deacetylase inhibitor therapy, followed by tumor resection, is feasible. METHODS: A phase I clinical trial using a two-staged multiple-agent design of bortezomib and vorinostat as induction therapy followed by consolidative surgery in patients with NSCLC was performed. Standard toxicity and maximum tolerated dose were examined. Pre- and post-treatment tumor gene-expression arrays were performed and analyzed. Pre- and post-treatment fluorodeoxyglucose-positron emission tomography imaging was used to assess tumor metabolism. Finally, serum 20S proteasome levels were analyzed with enzyme-linked immunosorbent assay, and selected intratumoral proteins were assessed by immunohistochemistry. RESULTS: Of the 34-four patients providing written consent to participate in the trial, 21 were enrolled. One patient withdrew early because of disease progression. The maximum tolerated dose was bortezomib 1.3 mg/m and vorinostat 300 mg twice daily. There were grade III dose-limiting toxicities of fatigue and hypophosphatemia, which were self-limited. There was no mortality. Thirty percent of patients (6 of 20) had more than 60% histologic necrosis of their tumor after treatment, with two having 90% or more tumor necrosis. Tumor metabolism, 20S proteasome activity, and specific protein expression did not demonstrate consistent results. Gene-expression arrays comparing pre- and post-therapy NSCLC specimens revealed robust intratumoral changes in specific genes. CONCLUSIONS: Induction bortezomib and vorinostat therapy followed by surgery in patients with operable NSCLC is feasible. Correlative gene-expression studies suggest new targets and cell-signaling pathways that may be important in modulating this combined therapy.

EUS-FNA as the initial diagnostic modality in centrally located primary lung cancers.

BACKGROUND AND AIMS: The need to safely and accurately diagnose lung neoplasms is crucial as the only prospect for a cure is surgical resection. A small amount of data exists on the use of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) as the initial diagnostic modality of primary lung cancer. METHODS: We performed a retrospective review of an established prospective database of all patients undergoing EUS-FNA of a primary lung neoplasm adjacent to the esophagus during January 2001 to August 2005 in one tertiary care center. The indications for the procedure, diagnostic accuracy, and complications were reviewed. RESULTS: A total of 17 cases (9 females, 8 males) were identified. The mean age was 66 (SD 10.6). There were 9 lesions within the hilum and 8 lesions within the upper lobes. The median size of the lung lesions was 5 (range 2 to 12)x4 (range 2 to 9) cm. The median and mean number of FNA passes was 3. All the procedures provided an accurate diagnosis of the primary lung lesion without need for further intervention. One patient with active hemoptysis was transiently hospitalized for aspiration pneumonia postprocedure. CONCLUSIONS: EUS-FNA is a safe, relatively cost-effective, and accurate initial diagnostic modality for the diagnosis of lung lesions adjacent to the esophagus or invading the mediastinum. Although further randomized prospective trials are warranted, this modality should be considered as a first step in the diagnostic armamentarium in centrally located lung lesions.

Clinical experience with radiotracer-guided thoracoscopic biopsy of small, indeterminate lung nodules.

BACKGROUND: Although computed tomography lung-screening programs report a 31% to 51% incidence of subcentimeter pulmonary nodules, 85% are too small to biopsy or interrogate with positron emission spectroscopy scans. We developed a technique using transthoracic percutaneous radiotracer injection with thoracoscopic radioprobe localization and excision for small pulmonary nodules. This report describes our series of the first 46 patients evaluated with this technique. METHODS: Forty-six patients (79% smokers; 52% males; median age, 64 years) were evaluated. Patient selection was based on the surgeon's anticipated difficulty in thoracoscopically locating small nodules because of lesion size or location. Computed tomographic-guided injection of radiotracer solution was made into or adjacent to the nodule the day of surgery. Intraoperative gamma probe localization, followed by thoracoscopic excision of the lesion, was subsequently performed. RESULTS: Median nodule size was 9 mm (range, 3 to 22 mm), and median depth was 5 mm (range, 0 to 50 mm). Forty-four (96%) of the lesions were successfully localized and excised. Median time from injection to surgery was 270 minutes. Failures were the result of inadvertent pleural or chest wall radiotracer placement. Forty-six percent (21 of 46) of the lesions were malignant, of which 71% (15 of 21) were primary lung cancers. Patients with lung cancer underwent lobectomy or segmentectomy. Fourteen of 15 were stage IA, whereas 1 was stage IIIB (6 mm primary with 4 mm intralobar metastasis). Complications were three pneumothoraces at the time of radiotracer injection. CONCLUSIONS: Computed tomography-guided radiotracer localization of small pulmonary nodules combined with thoracoscopic excisional biopsy is feasible and safe. This technique successfully localized and excised the nodule in 96% of cases.

Review of technology: planning for the development of telesonography.

Teleradiology allows contemporaneous interpretation of imaging exams performed at some distance from the interpreting radiologist. The transmitted images are usually static. However, there is benefit to real-time review of full-motion ultrasound (US) exams as they are performed. Telesonography is transmission of full-motion sonographic data to a remote site. We hypothesize that US exams, read after having been compressed utilizing Motion Picture Experts Group version 4 (MPEG-4) compression scheme, transmitted over the Internet as streaming multimedia, decompressed, and displayed, are equivalent in diagnostic accuracy to reading the examinations locally. MPEG-4 uses variable compression on each image frame to achieve a constant output bit rate. With less compression, the bit rate rises, and the only way the encoder can contain bit rate within the set bandwidth is by lowering frame rate or reducing image quality. We review the relevant technologies and industry standard components that will enable low-cost telesonography.